ACTUATE THERAPEUTICS, INC. (ACTU)
Data as of , from SEC Form 4 filings.
See up to 3 months of ACTU. The 7-day demo opens the 1M and 3M ranges and puts ACTU on your watchlist.
Start 7-day demoLatest ACTU insider trades
About ACTUATE THERAPEUTICS, INC. (ACTU)
The SEC lists ACTUATE THERAPEUTICS, INC. under CIK 0001652935, in pharmaceutical preparations. It is grouped with Health Care companies on this site. It filed a registration statement with the SEC on 6 October 2026 and has not yet priced an offering.
ACTU Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 544,112 | |
| Tax withholding / forfeiture | 1 | 120,521 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ACTU insider transactions (Form 4)
2015 Form 4 filings on record, the earliest from Apr 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel M. Schmitt - Officer | Option exercise | Common Stock | 272,056 footnote F3 | $0.00 footnote F4 | - | |
| Daniel M. Schmitt - Officer | Tax withholding / forfeiture | Common Stock | 120,521 footnote F1 | $1.01 footnote F2 | $122K | |
| Daniel M. Schmitt - Officer | Option exercise | Restricted Stock Units | 272,056 | $0.00 footnote F4 | - | |
| ||||||
| Dan Zabrowski - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Todd S. Thomson - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Roger Sawhney - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Amy L. Ronneberg - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Jason A. Keyes - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Grant or award | Stock Options | 15,000 | $0.00 | - | ||
| Aaron G.L. Fletcher - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Daniel M. Schmitt - Officer | Grant or award | Employee Stock Option (right to buy) | 237,000 | $0.00 | - | |
| Andrew Paul Mazar - Officer | Grant or award | Employee Stock Option (right to buy) | 105,000 | $0.00 | - | |
| Paul J. Lytle - Officer | Grant or award | Employee Stock Option (right to buy) | 105,000 | $0.00 | - | |
| Daniel M. Schmitt - Officer | Option exercise | Common Stock | 272,055 footnote F3 | $0.00 footnote F4 | - | |
| Daniel M. Schmitt - Officer | Tax withholding / forfeiture | Common Stock | 121,874 footnote F1 | $4.33 footnote F2 | $528K | |
| Daniel M. Schmitt - Officer | Option exercise | Restricted Stock Units | 272,055 | $0.00 footnote F4 | - | |
| ||||||
| Todd S. Thomson | Open-market sale | Common Stock | 280,000 | $5.80 | $1.62M | |
| Todd S. Thomson - Director | Grant or award | Stock Options | 15,000 | $0.00 | - | |
| Paul J. Lytle - Officer | Grant or award | Employee Stock Option (right to buy) | 49,394 | $0.00 | - | |
| Paul J. Lytle - Officer | Grant or award | Employee Stock Option (right to buy) | 41,899 | $0.00 | - | |
ACTU insider trading FAQ
What is the latest insider trade for ACTU?
ACTUATE THERAPEUTICS, INC. (ACTU) had 1 insider filing in the last 90 days, with the most recent on 2026-08-14. The full record for ACTU runs to 15 Form 4 filings, the earliest from 2025-04-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ACTU stock?
No insider purchases of ACTU were filed in the last 90 days.
How many insiders are selling ACTU stock?
No insider sales of ACTU were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ACTU SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ACTU Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel M. Schmitt view on EDGAR
- - Dan Zabrowski view on EDGAR
- - Todd S. Thomson view on EDGAR
- - Roger Sawhney view on EDGAR
- - Amy L. Ronneberg view on EDGAR
- - Jason A. Keyes view on EDGAR
- - Martin H. Huber Jr. view on EDGAR
- - Aaron G.L. Fletcher view on EDGAR
- - Daniel M. Schmitt view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ACTU's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ACTU with a 7-day demo
- ACTU on your watchlist
- Every ACTU Form 4 filing on record
- Up to 3 months of ACTU price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive